We are planning an information session about applying for social security disability benefits in the US. “Social Security pays benefits to people who cannot work because they have a medical condition that is expected to last at least one year or result in death.” However, successfully obtaining social security disability benefits can be very difficult because most people are unfamiliar with the law and the process. We will discuss how social security disability lawyers can assist people either with the initial application or appealing a decision of rejection, or when a request for reconsideration of Social Security’s denial of a disability is also rejected. Appealing a decision of rejection is much more complicated and time consuming than the initial application process, so the use of the expertise of a social security disability lawyer is even more important. Unfortunately, the application for SSD benefits is a time consuming process and statistically more than 60% of initial social security disability claims are rejected. Therefore, we believe this SSD information session will be most illuminating and helpful.
We are always interested in the most up to date research in the medical field that is now dominated by the insuppressible biopharma juggernaut. But there are also other fascinating research and development going on in various biotech fields. One fascinating area is in the environmental aspects of biotechnology. A European firm, Papernet, has developed and is marketing a biotech toilet paper contains five different types of good microorganisms, which are completely harmless. These microorganisms remove incrustations and smelly substances from sewage pipes. By constantly using Biotech toilet paper you will reduce the need for the mechanical cleaning of sewerage systems as well as reduce maintenance costs. Something as humble as toilet paper, albeit biotech toilet paper, clearly demonstrates how biotechnology is changing the world. We are eagerly awaiting the time when Papernet or the equivilent bio tech is available as both retail and wholesale toilet paper in the US. At the moment this extraordinary biotech toilet paper is only available in Europe through Papernet, which has the exclusive European rights. We are looking forward to more breakthroughs in biopharma along with environmental and agricultural aspects of biotechnology in the near future.
A new medicine to treat alcoholism, baclofen, is slowly gaining traction in the US as an alternative to AA 12 step abstinence programs or the use of the drug Disulfiram, also known by the brand name Antabuse, a medication that causes individuals to suffer from very unpleasant side effects when even trace amounts of alcohol have been ingested. Baclofen originally was developed to help relieve painful spasm, automatism, as well as clonus from a number of neurological diseases associated with spasm of the skeletal muscles. For a number of years doctors in Europe have been prescribing baclofen as the primary treatment for people who drink excessively. However in the US, it has not yet received approval by the U.S. Food & Drug Administration (FDA) as a safe and effective treatment for alcohol or drug use disorders. Preliminary open-label studies from Italy have demonstrated effectiveness of baclofen in reducing alcohol use among the alcoholics. In addition, results from a clinical study conducted by Brown University show alcohol-addicted participants receiving baclofen were able to abstain from drinking for longer periods of time than those who didn’t receive the drug. Baclofen treatment does require titration (slow dose increase) until a person’s cravings are completely removed or controlled. Even though it has some side effects as one’s body adjusts to it, the medication is worth checking out.
All attending participants to the AIDS Vilnius conference as well as the honorable and esteemed scientific committee members are receiving lavish gift baskets from GiftTree as a show of appreciation for all their hard work. Our hospitality committee has selected gourmet gift baskets, fruit gift baskets, and specialty wine gift baskets personalized for each recipient. We hope that the personalized engraved and embossed gifts found within the gift baskets will create a permanent reminder of this important AIDS Vilnius 2009 conference for years to come. Our hospitality committee is also available to assist any conference participant in ordering flowers or perhaps a gift basket as a thank you to their own support staff or colleagues who were unable to attend but assisted from afar.
And finally for those participant who would like to bring home to family members a memento of the 2009 AIDS Vilnius conference, we have a variety of engraved gifts with the conference’s logo and the date, including a special gift for young golfers. We’ve made arrangements with AllKidsGolfClubs.com to provide a unique collection of kids golf clubs & accessories, engraved with the 2009 conference logo for parents of young golf enthusiasts. The golf sets include 5 clubs and a package of 10 balls, all carrying our logo. Arrangements can be made to ship this gift home prior to the conference conclusion.
1. Prof. Henrique Barros, HIV/AIDS National Coordinator, Ministry of Health. Head. Department of Hygiene and Epidemiology University of Porto Medical School, Portugal
2. Prof. Dr. Prakash Chandra, Dr.phil.nat.,C.Chem.,FRSC (London). Frankfurt University Medical School, Germany. Adj. Prof.of Medicine, University of Maryland Medical School, USA (chairman)
3. Mr Martin Donoghoe, Communicable Diseases Unit, WHO Europe, Copenhagen, Denmark
4. Dr Irina Eramova, Communicable Diseases Unit, WHO Europe, Copenhagen, Denmark
5. Prof. Dr. Daniel Gredig, School of Social Work, University of Applied Sciences Northwestern Switzerland, Switzerland
6. Prof. Andrzej Horban, AIDS&hepatitis Diagnostic and Therapy Center Warsaw, Poland
7. Prof. Luminita Smaranda Iancu, University of Medicine and Pharmacy “Gr. T. Popa” Iaşi, Faculty of Medicine. Romania
8. Irena Klavs, Head of AIDS/STD Unit, Centre of communicable diseases, Institute of Public Health of Slovenia
9. Prof. Andrei Kozlov, Director, Biomedical Centre. Prof., Sanct. Petersburg University, Russia
10. Prof. Pauli Leinikki, Chairman of the HIV/AIDS Expert Group, Nordic Dimension Partnership in Public Health and Social Well-being, Public Department of Infectious Diseases Epidemiology, National Public Health Institute, Finland
11. Prof. Vladimir Lukashov, Department of Human Retrovirology, Academic Medical Centre, University of Amsterdam, Amsterdam Institute of Viral Genomics, The Netherlands
12. Prof. Jens D. Lundgren, Centre for Viral Diseases, Copenhagen, Denmark
13. Jean-Elie MALKIN, Counsellor, Infection and Epidemiology Research Department, Pasteur Institute, France
14. Ulrich Markus; Deputy Director, Robert Koch-Institute; Germany
15. Robert G. Newman, Director, International Center for Advancement of Addiction Treatment, Baron Edmond de Rothschild Chemical Dependency Institute of Beth Israel Medical Center, Israel
16. Jacques Normand, Director, AIDS Research Program, National Institute on Drug Abuse, National Institutes of Health, USA
17. Prof. Alvydas Pumputis, Rector, Mykolas Romeris University, Lithuania
18. Prof. Baiba Rozentale, Director Infectology Centre of Latvia
19. Jon Sigfusson, Icelandic Centre for Social Research and Analysis, Reykjavik University, Iceland
20. Prof Anders Sönnerborg, Center for HIV Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm Sweden
21. Kai Zilmer, Reference Laboratory of HIV Infection, West-Tallinn Central Hospital, Estonia
22. Dr. Marita JW van de Laar, programme coordinator HIV/AIDS, STI and viral hepatitis, European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.